![Megan Knight](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Megan Knight
Investor Relations Contact chez
LONGBOARD PHARMACEUTICALS, INC.
Profil
Megan E.
Knight is currently Vice President & Head-Investor Relations at Longboard Pharmaceuticals, Inc. since 2021 and Vice President-Investor Relations at CG Oncology, Inc. starting in 2025.
Former roles include Director-Investor Relations at Arena Pharmaceuticals, Inc. from 2016 to 2020 and Head-Investor Relations & Corporate Communications at Senomyx, Inc. Education includes undergraduate studies at San Diego State University.
Postes actifs de Megan Knight
| Sociétés | Poste | Début |
|---|---|---|
| LONGBOARD PHARMACEUTICALS, INC. | Investor Relations Contact | 01/01/2021 |
| CG ONCOLOGY, INC. | Investor Relations Contact | 01/08/2025 |
Anciens postes connus de Megan Knight
| Sociétés | Poste | Fin |
|---|---|---|
| ARENA PHARMACEUTICALS | Investor Relations Contact | 01/01/2020 |
| SENOMYX INC. | Investor Relations Contact | - |
Formation de Megan Knight
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Senomyx, Inc.
 Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Discovers and develops novel flavors and taste modulators for the packaged food and beverage industry | Consumer Non-Durables |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CG Oncology, Inc.
 CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
Longboard Pharmaceuticals, Inc.
 Longboard Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for neurological diseases | Health Technology |
